Use of unlicensed drugs and off-label drug use: focus on COVID-19

Introduction. In a crisis, like the COVID-19 outbreak, the strategy of experimental drug use in clinical practice increases the availability of potentially effective drugs that have not yet proven the opposite for patients with life-threatening diseases, despite the fact that such use is «off-label»...

Cijeli opis

Bibliografski detalji

Glavni autori:	S. A. Mishinova, A. A. Zhuravkov, V. K. Zhuravko
Format:	Artigo
Jezik:	Russo
Izdano:	Izdatelstvo OKI 2020-10-01
Serija:	Качественная клиническая практика
Teme:	off-label назначение covid-19 расширенный доступ нежелательные лекарственные реакции клиническая фармакология жизнеугрожающие заболевания реальная клиническая практика
Online pristup:	https://www.clinvest.ru/jour/article/view/542
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!